Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level

Last updated: July 9, 2024
Sponsor: Taipei Veterans General Hospital, Taiwan
Overall Status: Active - Recruiting

Phase

2

Condition

Diabetes Mellitus, Type 2

Diabetes And Hypertension

Elevated Triglycerides (Hypertriglyceridemia)

Treatment

White job's tear

Taiwanese whole grain job's tear (red job's tear)

Clinical Study ID

NCT06503172
2024-04-005C
  • Ages 60-95
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Background: This investigation aims to explore efficacy of Taiwanese whole grain job's tear on muscle health and blood glucose and lipid levels in community-dwelling older adults.

Methods: An open-label, 16-week, randomized controlled, cross-over trial involving participants with subject complaint of slower gait or weakness or fall in last year were recruited. The intervention group consumed Taiwanese whole grain job's tear (red job's tear) or white job's tear. Assessments included laboratory tests, functional assessments, and body composition.

Eligibility Criteria

Inclusion

Inclusion Criteria:

People who aged 60-95 years

Patients with following characteristics:

feeling loss in activity detecting decline in self's walking speed. feeling tired of doing everything. having fall event in last year. People willing to follow the program and cooperate with us for following tracking.

People who are neither vegan nor vegetarian People agree and be able to sign the informed consent.

Exclusion

Exclusion Criteria:

People with any disease affecting their limbs, including:

having fracture on limbs in the past 6 months having severe arthritis in the past 6 months any other whom PI recognized as weak control of their nervous system( e.g.: Parkinson's disease and stroke).

People with intermittent limp caused by peripheral artery diseases People with weak control of mental disorder People with weak control of Cardiopulmonary disease People with weak control of Malignant tumor People with weak control of kidney diseases (eGFR <60ml/min/1.73) People with Visual impairment and Hearing disorder which cannot help to complete the program.

People who have underwent hormone treatment and planned to undergo hormone treatment during program session.

Any other condition that PI recognized as not suitable

Study Design

Total Participants: 80
Treatment Group(s): 2
Primary Treatment: White job's tear
Phase: 2
Study Start date:
June 14, 2024
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • Taipei Veterans General hospital

    Taipei, 112
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.